Switzerland· 38774213
Kenacort-A Solubile 10 mg/0.25 mL, Injektionslösung
A triamcinolone product containing triamcinoloni acetonidum, registered in Switzerland by Dermapharm AG and dispensed under Swissmedic category B. The same ATC class is registered in 14 of our 19 countries.
Checked against Swissmedic (Switzerland) on
Informational only — not a medical device.
Where it is registered
Triamcinolone is registered in 14 of 19 countries.
Countries holding a registration under ATC H02AB08 (triamcinolone), each read from that country’s own register.
- This record: Switzerland, from Swissmedic (Switzerland)
- 8 of them publish a price we can compare per daily dose
Triamcinolone · ATC H02AB08
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of triamcinolone costs, country by country.
Normalised to the WHO defined daily dose (7.5 mg), so markets compare like for like.
- Switzerland: $1.42 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Triamcinolone · price per daily dose (7.5 mg)
USD · FX 28 Sept 2026
- CH Switzerland$1.42
The record
At a glance
Swissmedic (Switzerland)- Active substance
- triamcinoloni acetonidum
- Manufacturer
- Dermapharm AG
- Country
- Switzerland (CH)
- ATC code
- H02AB08
- ATC class
- Triamcinolone
- Defined daily dose
- 7.5 mg, O
- Swissmedic category
- B
- Reimbursed
- No
- Source register
- Swissmedic (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
806 interactions on record for triamcinolone.
Graded by severity as the source publishes them — 84 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Triamcinolone · interactions on record
806 records
- 84 severe
- 366 moderate
- 38 minor
- 298 info
Most severe, free to view
- LonafarnibA16AX20severe
- DesirudinB01AE01severe
- ConivaptanC03XA02severe
- Magnesium hydroxideA02AA04moderate
20 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under H02AB08
Triamcinolone, as other registers publish it.
- United KingdomAdcortyl Intra-articular / Intradermal 10mg/1ml suspension for injection ampoulesBristol-Myers Squibb Pharmaceuticals Ltd
- United KingdomAdcortyl Intra-articular / Intradermal 50mg/5ml suspension for injection vialsBristol-Myers Squibb Pharmaceuticals Ltd
- BelgiumAlbicort 10Sanofi Belgium
- BelgiumAlbicort 40 40 mg/mlSanofi Belgium
- BelgiumAlbicort 40 40 mg/mlSanofi Belgium
- BelgiumAlbicort 80 80 mg/2 mlSanofi Belgium
- NorwayHexatrioneEthypharm
- SwitzerlandKenacort
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ba7b60ac-b861-42e7-bab0-ec4de8863149 GET /v1/drugs/ba7b60ac-b861-42e7-bab0-ec4de8863149?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{}See everything about triamcinolone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.